Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytes

Molecular Immunology

Volumn 48, Issue 6-7, 2011, Pages 956-965

  Martin Chouly, Corinne ^a   Morzadec, Claudie ^a   Bonvalet, Mélodie ^a   Galibert, Marie Dominique ^b   Fardel, Olivier ^a,c   Vernhet, Laurent ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b CNRS   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

Heme oxygenase 1; Immunotoxicity; Inorganic arsenic; Interleukin 2; Lymphocytes

Indexed keywords

ARSENITE SODIUM; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEME OXYGENASE 1; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; LYMPHOTOXIN; MESSENGER RNA; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE RELEASE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ARSENITES; CELL SEPARATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; HEME OXYGENASE-1; HUMANS; IMMUNITY; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHYTOHEMAGGLUTININS; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION; SODIUM COMPOUNDS; STRESS, PHYSIOLOGICAL; T-LYMPHOCYTES; TIME FACTORS; TISSUE DONORS; UP-REGULATION;

EID: 79951558656     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.01.005     Document Type: Article

References (44)

1. Banerjee N., Banerjee S., Sen R., Bandyopadhyay A., Sarma N., Majumder P., Das J.K., Chatterjee M., Kabir S.N., Giri A.K. Chronic arsenic exposure impairs macrophage functions in the exposed individuals. J. Clin. Immunol. 2009, 29:94-582.
2. Biswas R., Ghosh P., Banerjee N., Das J.K., Sau T., Banerjee A., Roy S., Ganguly S., Chatterjee M., Mukherjee A., Giri A.K. Analysis of T-cell proliferation and cytokine secretion in the individuals exposed to arsenic. Hum. Exp. Toxicol. 2008, 27:6-381.
3. Boheler K., Volkoav M., Morrell C., Garg R., Margulies K., Seymour A.-M., Lakatta E. Sex- and age-dependent human transcriptome variability: implication for chronic heart failure. Proc. Natl. Acad. Sci. 2003, 100:2754-2759.
4. Bourdonnay E., Morzadec C., Sparfel L., Galibert M.D., Jouneau S., Martin-Chouly C., Fardel O., Vernhet L. Global effects of inorganic arsenic on gene expression profile in human macrophages. Mol. Immunol. 2009, 46:56-649.
5. Bourdonnay E., Morzadec C., Fardel O., Vernhet L. Redox-sensitive regulation of gene expression in human primary macrophages exposed to inorganic arsenic. J. Cell. Biochem. 2009, 107:47-537.
6. Cantrell D.A., Smith K.A. The interleukin-2 T-cell system: a new cell growth model. Science 1984, 224:6-1312.
7. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 1987, 47:42-936.
8. Ceuppens J.L., Baroja M.L., Lorre K., Van Damme J., Billiau A. Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal. J. Immunol. 1988, 141:74-3868.
9. Chung S.W., Hall S.R., Perrella M.A. Role of haem oxygenase-1 in microbial host defence. Cell Microbiol. 2009, 11:199-207.
10. Conde P., Acosta-Saavedra L.C., Goytia-Acevedo R.C., Calderon-Aranda E.S. Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells. Arch. Toxicol. 2007, 81:9-251.
11. Euvrard S., Kanitakis J., Claudy A. Skin cancers after organ transplantation. N. Engl. J. Med. 2003, 348:91-1681.
12. Fan J., Nishanian P., Breen E.C., McDonald M., Fahey J.L. Cytokine gene expression in normal human lymphocytes in response to stimulation. Clin. Diagn. Lab. Immunol. 1998, 5:40-335.
13. Galicia G., Leyva R., Tenorio E.P., Ostrosky-Wegman P., Saavedra R. Sodium arsenite retards proliferation of PHA-activated T cells by delaying the production and secretion of IL-2. Int. Immunopharmacol. 2003, 3:82-671.
14. Ghosh P., Roy C., Das N.K., Sengupta S.R. Epidemiology and prevention of chronic arsenicosis: an Indian perspective. Indian J. Dermatol. Venereol. Leprol. 2008, 74:93-582.
15. Gonsebatt M.E., Vega L., Herrera L.A., Montero R., Rojas E., Cebrian M.E., Ostrosky-Wegman P. Inorganic arsenic effects on human lymphocyte stimulation and proliferation. Mutat. Res. 1992, 283:5-91.
16. Gonsebatt M.E., Vega L., Montero R., Garcia-Vargas G., Del Razo L.M., Albores A., Cebrian M.E., Ostrosky-Wegman P. Lymphocyte replicating ability in individuals exposed to arsenic via drinking water. Mutat. Res. 1994, 313:9-293.
17. Goytia-Acevedo R.C., Cebrian M.E., Calderon-Aranda E.S. Differential effects of arsenic on intracellular free calcium levels and the proliferative response of murine mitogen-stimulated lymphocytes. Toxicology 2003, 189:44-235.
18. Hackett R.J., Davis L.S., Lipsky P.E. Comparative effects of tumor necrosis factor-alpha and IL-1 beta on mitogen-induced T cell activation. J. Immunol. 1988, 140:44-2639.
19. Jungo F., Dayer J.M., Modoux C., Hyka N., Burger D. IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact. Cytokine 2001, 14:82-272.
20. Kapturczak M.H., Wasserfall C., Brusko T., Campbell-Thompson M., Ellis T.M., Atkinson M.A., Agarwal A. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am. J. Pathol. 2004, 165:53-1045.
21. Kumagai Y., Sumi D. Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Annu. Rev. Pharmacol. Toxicol. 2007, 47:62-243.
22. Lemarie A., Morzadec C., Merino D., Micheau O., Fardel O., Vernhet L. Arsenic trioxide induces apoptosis of human monocytes during macrophagic differentiation through nuclear factor-kappaB-related survival pathway down-regulation. J. Pharmacol. Exp. Ther. 2006, 316:14-304.
23. Lemarie A., Morzadec C., Bourdonnay E., Fardel O., Vernhet L. Human macrophages constitute targets for immunotoxic inorganic arsenic. J. Immunol. 2006, 177:27-3019.
24. Lemarie A., Bourdonnay E., Morzadec C., Fardel O., Vernhet L. Inorganic arsenic activates reduced NADPH oxidase in human primary macrophages through a Rho kinase/p38 kinase pathway. J. Immunol. 2008, 180:7-6010.
25. Nohara K., Ao K., Miyamoto Y., Suzuki T., Imaizumi S., Tateishi Y., Omura S., Tohyama C., Kobayashi T. Arsenite-induced thymus atrophy is mediated by cell cycle arrest: a characteristic downregulation of E2F-related genes revealed by a microarray approach. Toxicol. Sci. 2008, 101:38-226.
26. Pae H.O., Oh G.S., Choi B.M., Chae S.C., Kim Y.M., Chung K.R., Chung H.T. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J. Immunol. 2004, 172:51-4744.
27. Page J.L., Johnson M.C., Olsavsky K.M., Strom S.C., Zarbl H., Omiecinski C.J. Gene expression profiling of extracellular matrix as an effector of human hepatocyte phenotype in primary cell culture. Toxicol. Sci. 2007, 97:97-384.
28. Rahman M.M., Ng J.C., Naidu R. Chronic exposure of arsenic via drinking water and its adverse health impacts on humans. Environ. Geochem. Health 2009, 31(Suppl. 1):189-200.
29. Raqib R., Ahmed S., Sultana R., Wagatsuma Y., Mondal D., Hoque A.M., Nermell B., Yunus M., Roy S., Persson L.A., Arifeen S.E., Moore S., Vahter M. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol. Lett. 2009, 185:197-202.
30. Robb R.J., Munck A., Smith K.A. T cell growth factor receptors. Quantitation, specificity, and biological relevance. J. Exp. Med. 1981, 154:74-1455.
31. Schuhmacher-Wolz U., Dieter H.H., Klein D., Schneider K. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects. Crit. Rev. Toxicol. 2009, 39:98-271.
32. Selgrade M.K. Immunotoxicity: the risk is real. Toxicol. Sci. 2007, 100:32-328.
33. Sheftel A.D., Kim S.F., Ponka P. Non-heme induction of heme oxygenase-1 does not alter cellular iron metabolism. J. Biol. Chem. 2007, 282:6-10480.
34. Smyth M.J., Godfrey D.I., Trapani J.A. A fresh look at tumor immunosurveillance and immunotherapy. Nat. Immunol. 2001, 2:9-293.
35. Soriano F.X., Baxter P., Murray L.M., Sporn M.B., Gillingwater T.H., Hardingham G.E. Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin. Mol. Cells 2009, 27:82-279.
36. Soto-Pena G.A., Luna A.L., Acosta-Saavedra L., Conde P., Lopez-Carrillo L., Cebrian M.E., Bastida M., Calderon-Aranda E.S., Vega L. Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. FASEB J. 2006, 20:81-779.
37. Soto-Pena G.A., Vega L. Arsenic interferes with the signaling transduction pathway of T cell receptor activation by increasing basal and induced phosphorylation of Lck and Fyn in spleen cells. Toxicol. Appl. Pharmacol. 2008, 230:26-216.
38. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science Y 1987, 235:6-1043.
39. Sun X., Pi J., Liu W., Hudson L.G., Liu K.J., Feng C. Induction of heme oxygenase 1 by arsenite inhibits cytokine-induced monocyte adhesion to human endothelial cells. Toxicol. Appl. Pharmacol. 2009, 236:9-202.
40. Urs S., Smith C., Campbell B., Saxton A.M., Taylor J., Zhang B., Snoddy J., Jones Voy B., Moustaid-Moussa N. Gene expression profiling in human preadipocytes and adipocytes by microarray analysis. J. Nutr. 2004, 134:70-762.
41. Vega L., Ostrosky-Wegman P., Fortoul T.I., Diaz C., Madrid V., Saavedra R. Sodium arsenite reduces proliferation of human activated T-cells by inhibition of the secretion of interleukin-2. Immunopharmacol. Immunotoxicol. 1999, 21:20-203.
42. Woo J., Iyer S., Cornejo M.C., Mori N., Gao L., Sipos I., Maines M., Buelow R. Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32). Transpl. Immunol. 1998, 6:84-93.
43. Yamashita K., McDaid J., Ollinger R., Tsui T.Y., Berberat P.O., Usheva A., Csizmadia E., Smith R.N., Soares M.P., Bach F.H. Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J. 2004, 18:7-765.
44. Zhang B., Schmoyer D., Kirov S., Snoddy J. GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinform. 2004, 5:16.